Perceptyne
PrivateLast Round
Seed
Oct 14, 2024
Est. Valuation
$4.5M
Total Funding Raised
$3.55M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Perceptyne operates in Frontier & Industrial Tech and is based in Hyderabad. Its latest recorded funding round was a Seed round in October 2024.
Perceptyne is an industrial automation company that develops AI-powered, dexterous semi-humanoid robots for manufacturing and assembly tasks.
Sector
Frontier & Industrial Tech
Verticals
Industrial Robotics, Warehouse Automation, Smart Manufacturing, Computer Vision, Computing Hardware
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perceptyne Comparables
Compare Perceptyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agility Robotics | 77% | |
| 1X Technologies | 76% | |
| Apptronik | 76% |
For institutional investors. Book with your work email.
Perceptyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 14, 2024 | ||||
| Pre Seed | May 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Perceptyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Endiya Partners | Seed |
| Z21 Ventures | Pre Seed |
| Venture Catalysts | Pre Seed |
| Whiteboard Capital | Seed |
| T-Hub | Pre Seed |
| Yali Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2026
Open roles increased to 33, representing 79% of headcount.
- Aug 20, 2026
Monthly visitors increased 79% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 22, 2026
Perceptyne is developing PR-OMNI, a mobile semi-humanoid designed to handle repetitive, dexterity-intensive manufacturing tasks and bring human-like dexterity to industrial automation in India.
For institutional investors. Book with your work email.
Perceptyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Perceptyne's valuation, stock price, and market status.
Is Perceptyne a public or private company?
Perceptyne is a private company.
What is the current stock price of Perceptyne?
Perceptyne is a private company, so its shares have no public market price. Caplight tracks Perceptyne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Perceptyne worth (valuation)?
Perceptyne's valuation is estimated at $4.5M based on funding round data.
Can I buy Perceptyne stock?
Perceptyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Perceptyne's last funding round?
Perceptyne's most recent funding round was Seed on October 14, 2024.
Who are the main investors in Perceptyne?
Key investors in Perceptyne include Endiya Partners, Venture Catalysts, Yali Capital.
Will Perceptyne IPO soon?
No public IPO plans have been announced for Perceptyne.
How can I track Perceptyne secondary market activity?
Caplight tracks bids, offers, and trades in Perceptyne's shares on secondary markets.